Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-AnalysisQuisette P. Janssen, Bas Groot Koerkamp, Nathan Bahary et al.|JNCI Journal of the National Cancer Institute|2019Cited by 299
Neoadjuvant folfirinox in patients with (borderline) resectable pancreatic cancer: A systematic review and patient-level meta-analysisStefan Buettner, Sing Yu Moorcraft, Quisette P. Janssen et al.|HPB|2020Cited by 8
Hydroxychloroquine reduces metastatic tumor burden in pancreatic adenocarcinoma through myeloperoxidase inhibitionBritney Niemann, Brian A. Boone|Journal of Inflammation|2025Cited by 3